|
antibody |
6 |
|
coronavirus |
6 |
|
transmission |
6 |
|
antibodies |
5 |
|
china |
4 |
|
coronavirus disease 2019 |
4 |
|
covid‐19 |
4 |
|
guangdong |
4 |
|
intensive care unit |
4 |
|
sars-cov-2 |
4 |
|
sars‐cov‐2 |
4 |
|
seroprevalence |
4 |
|
epidemiology |
3 |
|
influenza |
3 |
|
nucleocapsid |
3 |
|
serology |
3 |
|
acute respiratory tract infection |
2 |
|
adjuvants |
2 |
|
airborne transmission |
2 |
|
animal model |
2 |
|
antibody responses |
2 |
|
antiviral |
2 |
|
antiviral resistance |
2 |
|
avian influenza |
2 |
|
avian influenza virus |
2 |
|
cellular immunity |
2 |
|
children |
2 |
|
coronavirus disease 2019 (covid-19) |
2 |
|
covid-19 |
2 |
|
cytokines |
2 |
|
egg-adaptation |
2 |
|
epidemic |
2 |
|
ferret |
2 |
|
ferret model |
2 |
|
ferrets |
2 |
|
h10n1 |
2 |
|
h1n1 |
2 |
|
h4n2 |
2 |
|
h7n9 |
2 |
|
hemagglutinin |
2 |
|
human adenovirus |
2 |
|
humoral immunity |
2 |
|
immune correlate |
2 |
|
immunity |
2 |
|
infection |
2 |
|
influenza a(h3n2) |
2 |
|
influenza b virus |
2 |
|
influenza virus |
2 |
|
list of abbreviations. |
2 |
|
low pathogenic avian influenza |
2 |
|
modeling |
2 |
|
monocytes |
2 |
|
mouse |
2 |
|
mucosal immunity |
2 |
|
multibasic cleavage site |
2 |
|
neuraminidase |
2 |
|
nonstructural protein 1 |
2 |
|
novel vaccine platforms |
2 |
|
older adults |
2 |
|
outbreak |
2 |
|
pandemic |
2 |
|
public health |
2 |
|
quail |
2 |
|
respiratory virus |
2 |
|
seroconversion |
2 |
|
severe acute hepatitis |
2 |
|
severe acute respiratory syndrome coronavirus 2 (sars-cov-2) |
2 |
|
southern china |
2 |
|
stalk |
2 |
|
susceptible-exposed-infectious-removed (seir) |
2 |
|
tree shrew |
2 |
|
vaccine |
2 |
|
vaccine effectiveness |
2 |
|
vaccines |
2 |
|
western pacific |
2 |
|
wild bird |
2 |
|
zoonosis |
2 |
|
alzheimer's disease |
1 |
|
amperometry |
1 |
|
anseriformes |
1 |
|
anti-inflammatory |
1 |
|
anti-viral |
1 |
|
arbovirus |
1 |
|
aurantiamide acetate (pubchem cid:9832120) |
1 |
|
avian |
1 |
|
avian viruses |
1 |
|
baphicacanthus cusia root |
1 |
|
bdnf |
1 |
|
cd80 |
1 |
|
cell encapsulation |
1 |
|
cell therapy |
1 |
|
charadriiformes |
1 |
|
chimeric viruses |
1 |
|
chromaffin cell |
1 |
|
cochlear implant |
1 |
|
cxcl10 |
1 |
|
deafness |
1 |
|
dna |
1 |
|
dsrna binding |
1 |
|
encapsulation |
1 |
|
encephalitis |
1 |
|
endocytosis |
1 |
|
exocytosis |
1 |
|
ferret model transmission |
1 |
|
fusion |
1 |
|
g45r |
1 |
|
hdac6 |
1 |
|
hearing loss |
1 |
|
histone deacetylase 6 |
1 |
|
iav |
1 |
|
il15 |
1 |
|
infectious disease |
1 |
|
influenza a virus |
1 |
|
japanese encephalitis vaccine |
1 |
|
knockout mice |
1 |
|
lentivirus |
1 |
|
lipofection |
1 |
|
mucosal |
1 |
|
neurotrophin |
1 |
|
ns1 |
1 |
|
nucleofection |
1 |
|
oral |
1 |
|
parkinson's disease |
1 |
|
plant-derived |
1 |
|
poxvirus |
1 |
|
prime-boost |
1 |
|
quantal release |
1 |
|
respiratory viruses |
1 |
|
retinal degeneration |
1 |
|
rig-i |
1 |
|
sensorineural hearing loss |
1 |
|
sindbis virus |
1 |
|
sphingosine kinase 1 |
1 |
|
sphingosine-1-phosphate |
1 |
|
spiral ganglion neuron |
1 |
|
type i ifn |
1 |
|
type i interferon |
1 |
|
vaccination |
1 |
|
viral pathogenesis |
1 |
|
virus replication |
1 |
|
vlp |
1 |
